|
Post by mytakeonit on Jun 26, 2019 15:19:53 GMT -5
It has been said that time is but an illusion. Nowhere is this more true than..."The Twilight Zone" (1959-1964).
But But ... Yeah, my butt was slightly off.
Butt, that's mytakeonit
|
|
|
Post by mytakeonit on Jun 26, 2019 15:27:51 GMT -5
As far as the car goes, it would have been gone way before all those problems turned up. But, in the case of Afrezza ... it is a breath of fresh air. We will make it ... no problemO!
But, that's mytakeonit
|
|
|
Post by wgreystone on Jun 26, 2019 16:49:36 GMT -5
Spencer on ST $MNKD what I am going to say here is not a defense of MC, but rather the reality that I have been discussing for a long time. MNKD has been in a perpetual cash crunch for years. That cash crunch means you cant deliver optimal results. Example. Your car needs work...it needs brakes, transmission work, the radiator is worn, a new battery, new alternator, and the AC is not cold. You have $1,000 that you can spend. You need the brakes to pass inspection. Gotta do it. You need the alternator and battery for the car to run. Gotta do it. The tranmission, radiator, and AC gotta wait. You can buy tranny fluid, top off the radiator weekly, and roll down the windows. Heck, Fall is coming, so the AC can wait til next year. You see, even with the best intentions, you can not solve it all. You can take out a loan and get it all done, but that means it's harder to feed the family. Point is that fixing it all is not easy. Next post.... That being said, if you punt on these needed repairs, but go on a vacation to disney, pay for every cable channel, and go out to dinner thrice a week, are your priorities really where they need to be? I think shareholders can grasp why some things were kicked down the road, but find it difficult to swallow doing so whilst doing trips to Hawaii, ad campaigns, moving to a more expensive office location, sponsoring an indy car, Monaco trips. An annual meeting at a hotel instead of Danbury, etc. Next post.... A very real consideration is whether the all of this money should be invested into the car. It has a ton of miles anyway, and the problems seem to keep stacking up. Is a new car the better solution? That question needs to be addressed about Afrezza. It is no longer a new car. Is it better to trade it off, even for less value than you should get, and focus efforts into a new car? The hard part is that you still are a year away from saving enough to buy the new car. That means, even though expensive, using Uber, Lyft, and maybe even convincing your friends to give you rides for a while. At some point your friends get tired of you mooching (dilution), and they dont take your calls anymore. MC has been in a tough situation all along. Whether it could have been done better is a hot debate...next post What we have to REALLY consider is what is the strategy GOING FORWARD. Do we get rid of the car? The driver? What would a new car look like? Is a new driver going to be able to do better? Bottom line... an outline of what path is used needs to be supplied by management AS WELL AS any potential activist investor initiative. Otherwise we are just spinning wheels as the car gets older, gets more miles on it and loses value. Afrezza is a $2b car. Just need a good driver. No money for a new car.
|
|
bac
Lab Rat
Posts: 37
|
Post by bac on Jun 26, 2019 17:02:05 GMT -5
MannKind obviously needs to increase: •Afrezza retention rate •Afrezza scripts rate
Here is how to achieve the obvious: •Get new BOD’s with insulin experience •Get new CEO with insulin experience •Get a plan for increasing scripts & retention, vetted by BOD & CEO
CEO Mike C. has tried several approaches (some wacko) w/o success. It is past time for a change. In addition, his lack of integrity makes him unsuitable for a CEO position IMO. (For reference, read Good to Great by Jim Collins)
If a candidate CEO cannot put forth coherent ideas for a plan to double scripts in each of the next two years…thanks, next candidate please.
I’m using “scripts”, in lieu of quarterly net Afrezza income to MannKind, because current income is unsustainably benefiting from growth in $/script. $/script is increasing due to better understanding of Afrezza titration (new patients must use a lot more Afrezza units than SC insulin units). Once titration is well understood by prescribers, $/script will level off. (In other words, increasing $/script will improve income without any increase in scripts!) Current scripts are increasing at a rate LESS THAN LINEAR (albeit with lots of noise)!!!
|
|
|
Post by lifebreath on Jun 26, 2019 18:02:50 GMT -5
I wonder how many no voters will want to change their vote once we are under one dollar and MC does a reverse split. I wonder how many of the YES voters will change their vote if we don't go under one dollar and we don't have a reverse split? You set the bar way too easy. Would a restructured debt deal, like the one SO talked about buy us more time, getting DFLD, US Bank and Mann Group out of the way (in combination of any three), announcement of another molecule and more money from UTHR change votes. I hope you are right! But unfortunately one is staring us in the face and the other is the same dream and rhetoric I have heard since owning this stock
|
|
|
Post by morfu on Jun 26, 2019 18:30:11 GMT -5
He does that and it’s over. We all know it. Too many toxic deals have been made where they gave the shorts control. Not saying it was Mike.. it was the Board of Directors.. all of them just like matt says. What troubles me is that he still has no clear strategy to drive Afrezza growth. He is now betting on TreT to bring the company break even. Well, it is growing fast! You might wish for higher numbers, but doubling the revenue every year is good!
But since the chat is down to money again, let me present my numbers.. The total revenue for adult US Afrezza users should be around 50mil$ .. hopefully a bit more. Of which about 42% will go to Mannkind (or hopefully a bit more) Let´s say that is about 30mil$ and we already got one UTHR payment, let there be two more this year that´s close to 40mil$, The burn rate per month is something like 7mil$/month, that means we might be less than 20mil$ short this year.
|
|
|
Post by wgreystone on Jun 27, 2019 13:48:25 GMT -5
What troubles me is that he still has no clear strategy to drive Afrezza growth. He is now betting on TreT to bring the company break even. Well, it is growing fast! You might wish for higher numbers, but doubling the revenue every year is good!
But since the chat is down to money again, let me present my numbers.. The total revenue for adult US Afrezza users should be around 50mil$ .. hopefully a bit more. Of which about 42% will go to Mannkind (or hopefully a bit more) Let´s say that is about 30mil$ and we already got one UTHR payment, let there be two more this year that´s close to 40mil$, The burn rate per month is something like 7mil$/month, that means we might be less than 20mil$ short this year.
Scripts only grow less than 40% this year. $30m will be only revenue and you need to subtract cost.
|
|
|
Post by mnholdem on Jun 28, 2019 4:12:44 GMT -5
The vote count has flattened and posts in this thread are moving off topic. Locking this thread.
|
|